Prospective multicentre registry for children and adolescents with a relapsed/refractory haematological neoplasia, solid extracranial or CNS tumour as part of the promotion of the establishment of a network entitled “PECT-EAST” for the implementation of early clinical studies in paediatric oncology in the federal states of Berlin, Brandenburg, Mecklenburg- Vorpommern and Sachsen

Prospective multicentre registry for children and adolescents with a relapsed/refractory haematological neoplasia, solid extracranial or CNS tumour as part of the promotion of the establishment of a network entitled “PECT-EAST” for the implementation of early clinical studies in paediatric oncology in the federal states of Berlin, Brandenburg, Mecklenburg- Vorpommern and Sachsen - PECT- EAST Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037005

Enrollment

100

Registered

2025-05-26

Start date

2026-03-01

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

relapsed and refractory paediatric patients with haematological neoplasia, solid extracranial and CNS tumours

Interventions

Group 1: Prospective demographic survey of paediatric patients with relapsed/refractory haematological neoplasms, solid extracranial tumours and CNS tumours in the federal states of Berlin, Brandenbur

Eligibility

Sex/Gender

All

Age

0 Years to 25 Years

Inclusion criteria

Inclusion criteria: All paediatric patients with relapsed/refractory haematological neoplasia, solid extracranial or CNS tumours living in the federal states of Berlin, Brandenburg, Mecklenburg- Vorpommern and Sachsen up to the age of 0-25 years can be included.

Exclusion criteria

Exclusion criteria: There are no exclusion criteria.

Design outcomes

Primary

Measure	Time frame
The establishment of the PECT-EAST network structure in the federal states of Berlin, Brandenburg, Mecklenburg- Vorpommern and Sachsen with a central PECT-EAST register at Charité-Universitätsmedizin enables regional access to innovative drugs in early clinical trials and thus an increase in the number of enrolments for early clinical trials.	—

Secondary

Measure	Time frame
The establishment of the PECT-EAST network structure in the federal states of Berlin, Brandenburg, Mecklenburg- Vorpommern and Sachsen with a central PECT-EAST registry at Charité-Universitätsmedizin supports the further development of basic scientific research findings and promotes the adaptation of clinical practice through the design, development and implementation of an innovative early clinical study for haematological neoplasms, solid extracranial and CNS tumours.	—

Measure

Time frame

The establishment of the PECT-EAST network structure in the federal states of Berlin, Brandenburg, Mecklenburg- Vorpommern and Sachsen with a central PECT-EAST registry at Charité-Universitätsmedizin supports the further development of basic scientific research findings and promotes the adaptation of clinical practice through the design, development and implementation of an innovative early clinical study for haematological neoplasms, solid extracranial and CNS tumours.

—

Countries

Germany

Contacts

Public ContactAnne Thorwarth

Charité - Universitätsmedizin Berlin

anne.thorwarth@charite.de+49 30 450 666488

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026